Hemodiafiltration Is Associated With Reduced Inflammation and Increased Bone Formation Compared With Conventional Hemodialysis in Children: The HDF, Hearts and Heights (3H) Study

被引:16
作者
Fischer, Dagmar-Christiane [1 ]
Smith, Colette [2 ]
De Zan, Francesca [3 ]
Bacchetta, Justine [4 ]
Bakkaloglu, Sevcan A. [5 ]
Agbas, Ayse [6 ]
Anarat, Ali [7 ]
Aoun, Bilal [8 ]
Askiti, Varvara [9 ]
Azukaitis, Karolis [10 ]
Bayazit, Aysun [7 ]
Bulut, Ipek Kaplan [11 ]
Canpolat, Nur [6 ]
Borzych-Duzalka, Dagmara [12 ]
Duzova, Ali [13 ]
Habbig, Sandra [14 ]
Krid, Saoussen [15 ]
Licht, Christoph [16 ]
Litwin, Mieczyslaw [17 ]
Obrycki, Lukasz [17 ]
Paglialonga, Fabio [18 ]
Rahn, Anja [1 ]
Ranchin, Bruno [4 ]
Samaille, Charlotte [19 ]
Shenoy, Mohan [20 ]
Sinha, Manish D. [21 ]
Spasojevic, Brankica [22 ]
Stefanidis, Constantinos J. [9 ]
Vidal, Enrico [23 ]
Yilmaz, Alev [24 ]
Fischbach, Michel [25 ,26 ]
Schaefer, Franz [26 ]
Schmitt, Claus Peter
Shroff, Rukshana [3 ]
机构
[1] Rostock Univ Med Ctr, Dept Pediat, Rostock, Germany
[2] UCL, Inst Global Hlth, Pediat Nephrol Unit, London, England
[3] UCL, Pediat Nephrol Unit, Great Ormond St Hosp, Children & Inst Child Hlth, London, England
[4] Univ Lyon, Hosp Civils Lyon, Pediat Nephrol Unit, Hop Femme Mere Enfant, Bron, France
[5] Gazi Univ Hosp, Pediat Nephrol Unit, Ankara, Turkey
[6] Cerrahpasa Med Sch, Pediat Nephrol Unit, Istanbul, Turkey
[7] Cukurova Univ, Pediat Nephrol Unit, Adana, Turkey
[8] Armand Trousseau Hosp, Pediat Nephrol Unit, Paris, France
[9] Panagiotis & Aglaia Kyriakou Childrens Hosp, Pediat Nephrol Unit, Athens, Greece
[10] Vilnius Univ, Clin Pediat, Fac Med, Pediat Nephrol Unit, Vilnius, Lithuania
[11] Ege Univ Fac Med, Pediat Nephrol Unit, Izmir, Turkey
[12] Ege Univ, Pediat Nephrol Unit, Fac Med, Izmir, Turkey
[13] Med Univ Gdansk, Pediat Nephrol Unit, Gdansk, Poland
[14] Hacettepe Univ, Pediat Nephrol Unit, Ankara, Turkey
[15] Univ Hosp Cologne, Pediat Nephrol Unit, Cologne, Germany
[16] Hop Necker Enfants Malad, Pediatr Nephrol Unit, Paris, France
[17] Hosp Sick Children, Pediat Nephrol Unit, Toronto, ON, Canada
[18] Childrens Mem Hlth Inst, Pediat Nephrol Unit, Warsaw, Poland
[19] Pediat Nephrol Unit, Fdn Ist Ricovero Cura Carattere Scientifi, Granda Osped Maggiore Policlin, Milan, Italy
[20] Ctr Hosp Univ Lille, Serv Nephrol Pediatr, Lille, France
[21] Royal Manchester Childrens Hosp, Pediat Nephrol Unit, Manchester, England
[22] London Childrens Hosp, Pediat Nephrol Unit, Kings Coll London Evelina, London, England
[23] Univ Childrens Hosp, Pediat Nephrol Unit, Belgrade, Serbia
[24] Univ Udine, Dept Med, Div Pediat, Udine, Italy
[25] Istanbul Univ, Pediat Nephrol Unit, Fac Med, Istanbul, Turkey
[26] Childrens Dialysis Ctr, Strasbourg, France
关键词
hemodiafiltration; hemodialysis; inflammation; mineral bone disease; pediatric nephrology; CHRONIC KIDNEY-DISEASE; GROWTH-FACTOR; 23; LEFT-VENTRICULAR HYPERTROPHY; TNF-ALPHA; ONLINE HEMODIAFILTRATION; CLINICAL-PRACTICE; VASCULAR CALCIFICATION; SYSTEMIC INFLAMMATION; ALKALINE-PHOSPHATASE; BIOCHEMICAL MARKERS;
D O I
10.1016/j.ekir.2021.06.025
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Patients on dialysis have a high burden of bone-related comorbidities, including fractures. We report a post hoc analysis of the prospective cohort study HDF, Hearts and Heights (3H) to determine the prevalence and risk factors for chronic kidney disease-related bone disease in children on hemodiafiltration (HDF) and conventional hemodialysis (HD). Methods: The baseline cross-sectional analysis included 144 children, of which 103 (61 HD, 42 HDF) completed 12-month follow-up. Circulating biomarkers of bone formation and resorption, inflammatory markers, fibroblast growth factor-23, and klotho were measured. Results: Inflammatory markers interleukin-6, tumor necrosis factor-alpha, and high-sensitivity C-reactive protein were lower in HDF than in HD cohorts at baseline and at 12 months (P < .001). Concentrations of bone formation (bone-specific alkaline phosphatase) and resorption (tartrate-resistant acid phosphatase 5b) markers were comparable between cohorts at baseline, but after 12-months the bone-specific alkaline phosphatase/tartrate-resistant acid phosphatase 5b ratio increased in HDF (P = .004) and was unchanged in HD (P = .44). On adjusted analysis, the bone-specific alkaline phosphatase/tartrate-resistant acid phosphatase 5b ratio was 2.66-fold lower (95% confidence interval, -3.91 to -1.41; P < .0001) in HD compared with HDF. Fibroblast growth factor-23 was comparable between groups at baseline (P = .52) but increased in HD (P < .0001) and remained unchanged in HDF (P = .34) at 12 months. Klotho levels were similar between groups and unchanged during follow-up. The fibroblast growth factor-23/klotho ratio was 3.86-fold higher (95% confidence interval, 2.15-6.93; P < .0001) after 12 months of HD compared with HDF. Conclusion: Children on HDF have an attenuated inflammatory profile, increased bone formation, and lower fibroblast growth factor-23/klotho ratios compared with those on HD. Long-term studies are required to determine the effects of an improved bone biomarker profile on fracture risk and cardiovascular health.
引用
收藏
页码:2358 / 2370
页数:13
相关论文
共 60 条
[1]   Hemodiafiltration is associated with reduced inflammation, oxidative stress and improved endothelial risk profile compared to high-flux hemodialysis in children [J].
Agbas, Ayse ;
Canpolat, Nur ;
Caliskan, Salim ;
Yilmaz, Alev ;
Ekmekci, Hakan ;
Mayes, Mark ;
Aitkenhead, Helen ;
Schaefer, Franz ;
Sever, Lale ;
Shroff, Rukshana .
PLOS ONE, 2018, 13 (06)
[2]   The consequences of chronic kidney disease on bone metabolism and growth in children [J].
Bacchetta, Justine ;
Harambat, Jerome ;
Cochat, Pierre ;
Salusky, Isidro B. ;
Wesseling-Perry, Katherine .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (08) :3063-3071
[3]   Bone evaluation in paediatric chronic kidney disease: clinical practice points from the European Society for Paediatric Nephrology CKD-MBD and Dialysis working groups and CKD-MBD working group of the ERA-EDTA [J].
Bakkaloglu, Sevcan A. ;
Bacchetta, Justine ;
Lalayiannis, Alexander D. ;
Leifheit-Nestler, Maren ;
Stabouli, Stella ;
Haarhaus, Mathias ;
Reusz, George ;
Groothoff, Jaap ;
Schmitt, Claus Peter ;
Evenepoel, Pieter ;
Shroff, Rukshana ;
Haffner, Dieter .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (03) :413-425
[4]   From skeletal to cardiovascular disease in 12 steps-the evolution of sclerostin as a major player in CKD-MBD [J].
Brandenburg, Vincent M. ;
D'Haese, Patrick ;
Deck, Annika ;
Mekahli, Djalila ;
Meijers, Bjorn ;
Neven, Ellen ;
Evenepoel, Pieter .
PEDIATRIC NEPHROLOGY, 2016, 31 (02) :195-206
[5]   Clearance of Sclerostin, Osteocalcin, Fibroblast Growth Factor 23, and Osteoprotegerin by Dialysis [J].
Carlson, Nicholas ;
Mortensen, Ole H. ;
Axelsen, Mette ;
Pedersen, Robert S. ;
Heaf, James G. .
BLOOD PURIFICATION, 2017, 44 (02) :122-128
[6]   Sclerostin and Dickkopf-1 in Renal Osteodystrophy [J].
Cejka, Daniel ;
Herberth, Johann ;
Branscum, Adam J. ;
Fardo, David W. ;
Monier-Faugere, Marie-Claude ;
Diarra, Danielle ;
Haas, Martin ;
Malluche, Hartmut H. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (04) :877-882
[7]   The use of bone turnover markers in chronic kidney disease-mineral and bone disorders [J].
Chiang, Cherie .
NEPHROLOGY, 2017, 22 :11-13
[8]   End-Stage Renal Disease, Inflammation and Cardiovascular Outcomes [J].
Dai, Lu ;
Golembiewska, Edyta ;
Lindholm, Bengt ;
Stenvinkel, Peter .
EXPANDED HEMODIALYSIS: INNOVATIVE CLINICAL APPROACH IN DIALYSIS, 2017, 191 :32-43
[9]   Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production [J].
David, Valentin ;
Martin, Aline ;
Isakova, Tamara ;
Spaulding, Christina ;
Qi, Lixin ;
Ramirez, Veronica ;
Zumbrennen-Bullough, Kimberly B. ;
Sun, Chia Chi ;
Lin, Herbert Y. ;
Babitt, Jodie L. ;
Wolf, Myles .
KIDNEY INTERNATIONAL, 2016, 89 (01) :135-146
[10]   Online hemodiafiltration in children and hypoparathyroidism: A single-centre series of cases [J].
de Montclos, Thomas Perouse ;
Ranchin, Bruno ;
Leclerc, Anne-Laure ;
Bertholet-Thomas, Aurelia ;
Belot, Alexandre ;
Cochat, Pierre ;
Bacchetta, Justine .
NEPHROLOGIE & THERAPEUTIQUE, 2014, 10 (01) :35-38